High levels of glucose and advanced glycation end products (AGE) in the serum of DM patients can directly induce the activation of inflammatory pathways and the production of reactive oxygen species (ROS) and vascular endothelial growth factor (VEGF) in synovial fibroblasts (29–31). The gene discussed is VEGFA; the disease is diabetes mellitus.